Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. (KDGTF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kdgtf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kindstar Globalgene Technology, Inc.You KDGTF | $675M | N/A | — | -$0.06 |
 Adcock Ingram Holdings Limited AIHLF | $624M | 7.40x | +99.9% | $5.85 |
 Columbia Care Inc. CCHWF | $521M | N/A | — | -$0.26 |
 Opthea Limited CKDXF | $602M | N/A | — | -$0.13 |
 Claritas Pharmaceuticals, Inc. CLAZF | $0M | 0.00x | -99.9% | $0.16 |
 Dong Fang Hui Le Inc. DFHL | $400M | N/A | — | -$0.00 |
 EBR Systems, Inc. EBRCZ | $262M | N/A | — | -$0.12 |
Industry Average 2 peers with valid PE | — | 3.70x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kindstar Globalgene Technology, Inc. (KDGTF) measures how much investors pay for each dollar of the company's trailing earnings. KDGTF's current PE ratio of N/A is calculated by dividing its stock price of $0.68 by its TTM earnings per share of -$0.06.
Frequently asked questions
KDGTF pe ratio · 6 questionsKDGTF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.68 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via KDGTF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kindstar Globalgene Technology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09